Insider · CIK 0001299065

Barlow David S

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001299065

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-01-28	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−6,000 sh	$0.14	−$846	2,397,377
2011-01-28	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−21K sh	$0.17	−$3,675	2,361,377
2011-01-28	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−17K sh	$0.15	−$2,550	2,403,377
2011-01-28	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−9,000 sh	$0.17	−$1,539	2,382,377
2011-01-28	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−6,000 sh	$0.16	−$960	2,391,377
2011-01-27	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−33K sh	$0.17	−$5,610	2,425,377
2011-01-27	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−5,000 sh	$0.18	−$900	2,420,377
2010-12-17	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−122K sh	$0.20	−$24.4K	2,458,377
2010-12-17	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−2,000 sh	$0.21	−$420	2,580,377
2010-12-17	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−31K sh	$0.19	−$5,890	2,582,377
2010-12-16	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−19K sh	$0.22	−$4,180	2,615,377
2010-12-16	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−24K sh	$0.21	−$5,040	2,634,377
2010-12-16	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−2,000 sh	$0.23	−$460	2,613,377
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.04	−$1,020	2,663,677
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−186 sh	$1.95	−$362.7	2,658,377
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.05	−$1,025	2,663,177
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$1.95	−$975	2,662,177
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−300 sh	$2.05	−$615	2,660,877
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$1.95	−$975	2,659,377
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−1,000 sh	$2.04	−$2,040	2,659,877
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$1.99	−$995	2,661,677
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$1.97	−$985	2,658,563
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$1.96	−$980	2,661,177
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−314 sh	$1.97	−$618.58	2,659,063
2010-01-14	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$1.95	−$975	2,662,677
2010-01-12	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.08	−$1,040	2,664,177
2010-01-12	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.08	−$1,040	2,666,177
2010-01-12	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.09	−$1,045	2,666,677
2010-01-12	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.08	−$1,040	2,665,677
2010-01-12	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−200 sh	$2.06	−$412	2,667,977
2010-01-12	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−800 sh	$2.07	−$1,656	2,667,177
2010-01-12	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−1,000 sh	$2.08	−$2,080	2,664,677
2009-12-24	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.34	−$1,170	2,668,177
2009-12-24	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.34	−$1,170	2,668,677
2009-12-24	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.34	−$1,170	2,669,177
2009-12-24	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−1,000 sh	$2.34	−$2,340	2,669,677
2009-12-24	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.34	−$1,170	2,669,177
2009-12-24	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−500 sh	$2.34	−$1,170	2,668,677
2009-12-24	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−1,000 sh	$2.34	−$2,340	2,669,677
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−1,000 sh	$2.33	−$2,330	2,678,677
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−2,000 sh	$2.32	−$4,640	2,679,677
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−2,000 sh	$2.31	−$4,620	2,681,677
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−2,000 sh	$2.40	−$4,800	2,674,777
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−2,000 sh	$2.41	−$4,820	2,672,777
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−1,000 sh	$2.41	−$2,410	2,671,777
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−900 sh	$2.37	−$2,133	2,676,777
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−2,000 sh	$2.32	−$4,640	2,679,677
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−1,000 sh	$2.33	−$2,330	2,678,677
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−2,000 sh	$2.31	−$4,620	2,681,677
2009-12-23	Molecular Insight Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−1,000 sh	$2.33	−$2,330	2,677,677

Recent filings

Accepted (ET)
Jan 284
Barlow David S0001299065-11-000001
SEC(opens sec.gov)
Dec 204
Barlow David S0001299065-10-000007
SEC(opens sec.gov)
Jan 214
Barlow David S0001299065-10-000005
SEC(opens sec.gov)

Companies

Address

640 LEWIS WHARF

BOSTON, MA, 02110